Bases moléculaires du gigantisme hypophysaire

Adénome hypophysaire; Gigantism; Gigantisme; GPR101 (G-Protein-coupled Receptor 101) gene; Isolated familial pituitary adenoma (FIPA); L''acro-gigantisme lié au chromosome X (X-LAG); L''adénome hypophysaire familial isolé (FIPA); Le gène GPR101 (G-Protein-coupled Receptor 101); Pituitary adenoma; X-linked acro-gigantism (X-LAG); Medicine (all); General Medicine

Disciplines :

Endocrinology, metabolism & nutrition

Author, co-author :

Beckers, Albert ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'endocrinologie clinique

Beckers, Pablo ; Centre Hospitalier Universitaire de Liège - CHU > > Service de génétique

ROSTOMYAN, Liliya ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'endocrinologie clinique

Daly, Adrian ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'endocrinologie clinique

Language :

French

Title :

Bases moléculaires du gigantisme hypophysaire

Publication date :

August 2022

Journal title :

Bulletin de l'Académie Nationale de Médecine

ISSN :

0001-4079

eISSN :

2271-4820

Publisher :

Elsevier Masson s.r.l.

Volume :

206

Issue :

Pages :

837 - 844

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://api.elsevier.com/content/article/PII:S0001407922001819?httpAccept=text/xml

Available on ORBi :

since 19 November 2022

Statistics

Number of views

82 (12 by ULiège)

Number of downloads

121 (5 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Rostomyan, L., Beckers, A., Petrossians, P., Chapter 1 - History of the identification of gigantism and acromegaly. Stratakis, C.A., (eds.) Gigantism and Acromegaly, 2021, Academic Press p. 1–16.
Blumberg, D.L., Sklar, C.A., David, R., Rothenberg, S., Bell, J., Acromegaly in an infant. Pediatrics 83 (1989), 998–1002.
Sotos, J.F., Overgrowth. Hormonal causes. Clin Pediatr (Phila) 35 (1996), 579–590.
Bhansali, A., Upreti, V., Dutta, P., Mukherjee, K.K., Nahar, U., Santosh, R., et al. Adolescent acromegaly: clinical parameters and treatment outcome. J Pediatr Endocrinol Metab 23 (2010), 1047–1054.
Personnier, C., Cazabat, L., Bertherat, J., Gaillard, S., Souberbielle, J.C., Habrand, J.L., et al. Clinical features and treatment of pediatric somatotropinoma: case study of an aggressive tumor due to a new AIP mutation and extensive literature review. Horm Res Paediatr 75 (2011), 392–402.
Daly, A.F., Rixhon, M., Adam, C., Dempegioti, A., Tichomirowa, M.A., Beckers, A., High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91 (2006), 4769–4775.
Fontana, E., Gaillard, R., [Epidemiology of pituitary adenoma: results of the first Swiss study]. Rev Med Suisse 5 (2009), 2172–2174.
Gruppetta, M., Mercieca, C., Vassallo, J., Prevalence and incidence of pituitary adenomas: a population based study in Malta. Pituitary 16 (2013), 545–553.
Agustsson, T.T., Baldvinsdottir, T., Jonasson, J.G., Olafsdottir, E., Steinthorsdottir, V., Sigurdsson, G., et al. The epidemiology of pituitary adenomas in Iceland, 1955–2012: a nationwide population-based study. Eur J Endocrinol 173 (2015), 655–664.
Day, P.F., Loto, M.G., Glerean, M., Picasso, M.F., Lovazzano, S., Giunta, D.H., Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina. Arch Endocrinol Metab 60 (2016), 554–561.
Al-Dahmani, K., Mohammad, S., Imran, F., Theriault, C., Doucette, S., Zwicker, D., et al. Sellar masses: an epidemiological study. Can J Neurol Sci 43 (2016), 291–297.
Daly, A.F., Beckers, A., The epidemiology of pituitary adenomas. Endocrinol Metab Clin North Am 49 (2020), 347–355.
Wautot, V., Vercherat, C., Lespinasse, J., Chambe, B., Lenoir, G.M., Zhang, C.X., et al. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein. Hum Mutat 20 (2002), 35–47.
Agarwal, S.K., Lee Burns, A., Sukhodolets, K.E., Kennedy, P.A., Obungu, V.H., Hickman, A.B., et al. Molecular pathology of the MEN1 gene. Ann N Y Acad Sci 1014 (2004), 189–198.
Thakker, R.V., Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol Cell Endocrinol 386 (2014), 2–15.
Poncin, J., Abs, R., Velkeniers, B., Bonduelle, M., Abramowicz, M., Legros, J.J., et al. Mutation analysis of the MEN1 gene in Belgian patients with multiple endocrine neoplasia type 1 and related diseases. Hum Mutat 13 (1999), 54–60.
Carney, J.A., Gordon, H., Carpenter, P.C., Shenoy, B.V., Go, V.L., The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 64 (1985), 270–283.
Valdes Socin, H.P.J., Stevens, V., Stevenaert, A., Beckers, A., Adénomes hypophysaires familiaux isolés non liés avec la mutation somatique NEM-1. Suivi de 27 patients. Ann Endocrinol (Paris), 61, 2000, 301.
Valdes-Socin, H., Jaffrain-Réa, M.L., Tamburrano, G., Cavagnini, F., Cicarelli, E., Colao, A., et al. (eds.) Familial isolated pituitary tumors: clinical and molecular studies in 80 patients, 2002, The Endocrine Society's 84th Annual Meeting, San Francisco, USA.
Beckers, A., Familial Isolated Pituitary Adenomas. 2004, The 9th International Workshop on Multiple Endocrine Neoplasia (MEN 2004), Bethesda, USA.
Daly, A.F., Jaffrain-Rea, M.L., Ciccarelli, A., Valdes-Socin, H., Rohmer, V., Tamburrano, G., et al. Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 91 (2006), 3316–3323.
Beckers, A., Aaltonen, L.A., Daly, A.F., Karhu, A., Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev 34 (2013), 239–277.
Vierimaa, O., Georgitsi, M., Lehtonen, R., Vahteristo, P., Kokko, A., Raitila, A., et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312 (2006), 1228–1230.
Daly, A.F., Vanbellinghen, J.F., Khoo, S.K., Jaffrain-Rea, M.L., Naves, L.A., Guitelman, M.A., et al. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 92 (2007), 1891–1896.
Daly, A.F., Tichomirowa, M.A., Petrossians, P., Heliovaara, E., Jaffrain-Rea, M.L., Barlier, A., et al. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab 95 (2010), E373–E383.
Rostomyan, L., Daly, A.F., Petrossians, P., Nachev, E., Lila, A.R., Lecoq, A.L., et al. Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients. Endocr Relat Cancer 22 (2015), 745–757.
Weinstein, L.S., Shenker, A., Gejman, P.V., Merino, M.J., Friedman, E., Spiegel, A.M., Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325 (1991), 1688–1695.
Schwindinger, W.F., Francomano, C.A., Levine, M.A., Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci U S A 89 (1992), 5152–5156.
Dumitrescu, C.E., Collins, M.T., McCune-Albright syndrome. Orphanet J Rare Dis, 3, 2008, 12.
Vasilev, V., Daly, A.F., Thiry, A., Petrossians, P., Fina, F., Rostomyan, L., et al. McCune-Albright syndrome: a detailed pathological and genetic analysis of disease effects in an adult patient. J Clin Endocrinol Metab 99 (2014), E2029–E2038.
Beckers, A., Jaffrain-Rea, M.-L., Daly, A.F., De la génétique des adénomes hypophysaires familiaux. Bull Acad Natl Med 193 (2009), 1557–1571.
Trivellin, G., Daly, A.F., Faucz, F.R., Yuan, B., Rostomyan, L., Larco, D.O., et al. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med 371 (2014), 2363–2374.
Beckers, A., Lodish, M.B., Trivellin, G., Rostomyan, L., Lee, M., Faucz, F.R., et al. X-linked acrogigantism syndrome: clinical profile and therapeutic responses. Endocr Relat Cancer 22 (2015), 353–367.
Daly, A.F., Lysy, P.A., Desfilles, C., Rostomyan, L., Mohamed, A., Caberg, J.H., et al. GHRH excess and blockade in X-LAG syndrome. Endocr Relat Cancer 23 (2016), 161–170.
Naves, L.A., Daly, A.F., Dias, L.A., Yuan, B., Zakir, J.C., Barra, G.B., et al. Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome. Endocrine 51 (2016), 236–244.
Beckers, A., Petrossians, P., Hanson, J., Daly, A.F., The causes and consequences of pituitary gigantism. Nat Rev Endocrinol 14 (2018), 705–720.
Melmed, S., Bronstein, M.D., Chanson, P., Klibanski, A., Casanueva, F.F., Wass, J.A.H., et al. A Consensus Statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14 (2018), 552–561.
Daly, A.F., Yuan, B., Fina, F., Caberg, J.H., Trivellin, G., Rostomyan, L., et al. Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects. Endocr Relat Cancer 23 (2016), 221–233.
Gordon, R.J., Bell, J., Chung, W.K., David, R., Oberfield, S.E., Wardlaw, S.L., Childhood acromegaly due to X-linked acrogigantism: long term follow-up. Pituitary 19 (2016), 560–564.
Lacovazzo, D., Caswell, R., Bunce, B., Jose, S., Yuan, B., Hernandez-Ramirez, L.C., et al. Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study. Acta Neuropathol Commun, 4, 2016, 56.
Rodd, C., Millette, M., Iacovazzo, D., Stiles, C.E., Barry, S., Evanson, J., et al. Somatic GPR101 Duplication Causing X-Linked Acrogigantism (XLAG)-Diagnosis and Management. J Clin Endocrinol Metab 101 (2016), 1927–1930.
Beckers, A., Fernandes, D., Fina, F., Novak, M., Abati, A., Rostomyan, L., et al. Paleogenetic study of ancient DNA suggestive of X-linked acrogigantism. Endocr Relat Cancer 24 (2017), L17–L20.
Trivellin, G., Bjelobaba, I., Daly, A.F., Larco, D.O., Palmeira, L., Faucz, F.R., et al. Characterization of GPR101 transcript structure and expression patterns. J Mol Endocrinol 57 (2016), 97–111.
Abboud, D., Daly, A.F., Dupuis, N., Bahri, M.A., Inoue, A., Chevigne, A., et al. GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11. Nat Commun, 11, 2020, 4752.
Borson-Chazot, F., Garby, L., Raverot, G., Claustrat, F., Raverot, V., Sassolas, G., et al. Acromegaly induced by ectopic secretion of GHRH: a review 30 years after GHRH discovery. Ann Endocrinol (Paris) 73 (2012), 497–502.
Franke, M., Daly, A.F., Palmeira, L., Tirosh, A., Stigliano, A., Trifan, E., et al. Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism. Am J Hum Genet 109 (2022), 553–570.
Beckers, A., Rostomyan, L., Potorac, I., Beckers, P., Daly, A.F., X-LAG: How did they grow so tall?. Ann Endocrinol (Paris) 78 (2017), 131–136.
Rostomyan, L., Pituitary Gigantism [dissertation] [Doctoral thesis]., 2021, University of Liège, P. P. P. SPRL, Belgium.